Regenerex Pharma (Regenerex Pharma) EV-to-Revenue : (As of Jun. 20, 2024)

Regenerex Pharma EV-to-Revenue Chart

Regenerex Pharma Annual Data
	Trend	Nov09	Nov10	Nov11	Nov12	Nov13	Nov14	Mar17	Mar18	Mar22	Mar23
EV-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

Regenerex Pharma Quarterly Data
	May14	Aug14	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Regenerex Pharma's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's EV-to-Revenue falls into.

Regenerex Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Regenerex Pharma's EV-to-Revenue for today is calculated as:

Regenerex Pharma's current Enterprise Value is $0.00 Mil.
Regenerex Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerex Pharma  (OTCPK:PEPT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Regenerex Pharma's PS Ratiofor today is calculated as:

Regenerex Pharma's share price for today is $0.00.
Regenerex Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerex Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma (Regenerex Pharma) Business Description